Suppr超能文献

比较卵巢癌肿瘤减灭术后多次肠切除与单次肠切除的发病率。

Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer.

机构信息

Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK.

Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK; Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:215-219. doi: 10.1016/j.ejogrb.2019.07.011. Epub 2019 Jul 13.

Abstract

OBJECTIVES

To assess the impact of multiple bowel resections on postoperative outcomes in stage IIIC-IV ovarian cancer (OC).

METHODS

From the Oxford OC database we retrieved consecutive patients who underwent bowel resection between January 2009 and November 2017. Patients were divided into two groups: single bowel resection (SBR) and MBR (≥2 bowel resections). The following outcomes were compared between the two groups: 30-day related and not related morbidity to bowel surgery, bowel diversion rate and time to start/restart adjuvant chemotherapy.

RESULTS

Thirty-five patients were in the MBR and 146 in the SBR group. The 30-day overall surgical-related complication and bowel specific complications rate was higher in MBR group than SBR group (54.3% vs. 23.9%, p < 0.001) and (25.7% vs. 10.5%, p = 0.035), respectively. The rate of bowel diversion was 97.7% in MBR vs. 26.7% in the SBR group (p = 0.021). Trend analysis showed a significant reduction in the rate of MBR after the introduction of NACT (p- for trend <0.001).

CONCLUSIONS

Our data show that MBR during OC surgery is associated with a higher rate of overall and bowel specific complication compared to SBR. The introduction of NACT is associated with a reduced rate of MBR.

摘要

目的

评估 IIIC-IV 期卵巢癌(OC)患者多次肠切除术对术后结局的影响。

方法

我们从牛津 OC 数据库中检索了 2009 年 1 月至 2017 年 11 月期间接受肠切除术的连续患者。患者分为两组:单肠切除术(SBR)和多肠切除术(MBR,≥2 次肠切除术)。比较两组之间的以下结果:30 天相关和不相关的肠手术发病率、肠转流率和开始/重新开始辅助化疗的时间。

结果

35 例患者在 MBR 组,146 例患者在 SBR 组。MBR 组的 30 天总手术相关并发症和肠特异性并发症发生率高于 SBR 组(54.3%比 23.9%,p<0.001)和(25.7%比 10.5%,p=0.035)。MBR 组的肠转流率为 97.7%,SBR 组为 26.7%(p=0.021)。趋势分析显示,在引入新辅助化疗后,MBR 的发生率显著降低(p<0.001)。

结论

我们的数据表明,与 SBR 相比,OC 手术中的 MBR 与更高的总体和肠特异性并发症发生率相关。引入新辅助化疗与 MBR 发生率降低相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验